Table 1 Patient, tumor, and treatment characteristics
Characteristic | Overall (N = 32) | Greater SUV response (%) (N = 16) | Lesser SUV response (%) (N = 16) | p-value |
|---|---|---|---|---|
Age (Years) | ||||
Median | 58.2 | 59.3 | 57.6 | 0.32 |
Range | 37-69 | 43-69 | 37-64 | |
Gender (%) | 0.43 | |||
Male | 23 (71.9) | 11 (34.4) | 12 (37.5) | 0.43 |
Female | 9 (28.1) | 5 (15.6) | 4 (12.5) | |
ECOG Performance | 0.26 | |||
ECOG 0-1 | 24 (75) | 11 (34.4) | 13 (40.6) | |
ECOG 2 | 8 (25) | 5 (15.6) | 3 (9.4) | |
Hemoglobin | 0.22 | |||
Median | 10.8 | 10.6 | 11.1 | |
Range | 9.4-16.2 | 9.4-15.2 | 9.7-16-4 | |
< 12 g/dl (%) | 21 (65.6) | 11 (34.4) | 10 (31.2) | |
≥ 12 g/dl (%) | 11 (34.4) | 5 (15.6) | 6 (18.8) | |
CA 19-9 (%) | 0.58 | |||
< 100 | 7 (21.9) | 4 (12.5) | 3 (9.4) | |
≥ 100 | 25 (78.1) | 12 (37.5) | 13 (40.6) | |
CEA (%) | 0.63 | |||
< 10 | 27 (84.4) | 13 (40.6) | 14 (37.5) | |
≥ 10 | 5 (15.6) | 3 (9.4) | 2 (12.5) | |
Pancreatic Primary (%) | 0.63 | |||
Head | 27 (84.4) | 14 (37.5) | 13 (40.6) | |
Body | 5 (15.6) | 2 (12.5) | 3 (9.4) | |
Nodal stage (%) | 0.14 | |||
0 | 13 (40.6) | 6 (18.8) | 7(21.9) | |
1 | 19 (59.4) | 10 (31.2) | 9 (28.1) | |
Weight loss (%) | 0.19 | |||
≥ 5% | 22 (68.8) | 14 (37.5) | 10 (31.2) | |
< 5% | 10 (31.2) | 2 (12.5) | 6 (18.8) | |
SUVmax | 0.45 | |||
Median | 14.5 | 14.0 | 15.1 | |
Range | 6.5-22.6 | 6.5-20.7 | 9.5-22.6 |